Update: Moderate lifetime drinking may lead to lower Alzheimer-related beta amyloid deposits in the brain

__ Time for a new edition of SharpBrains’ e‑newsletter. #1. First of all, it’s not all bad news this month. Study finds that moderate lifetime drinking may lead to lower Alzheimer-related beta amyloid deposits in the brain #2. And, talk about personalized medicine! This fascinating study showing how brain imaging (fMRI) + machine learning + intensive, non-invasive neurostimulation = targeted treatments that can maximize efficacy and minimize side effects: Reinventing depression treatment via transcranial magnetic brain stimulation (TMS) #3. Also, not a minute too soon … Meditation apps have gone mainstream in the covid-19 era and Digital health start-ups raised a record $3.1 billion in Q1; focus will likely evolve from providers to consumers and employers #4. Fyi, a very timely virtual event coming Tuesday April 28th, online: Explore strategies and tools to boost mental wellbeing during (and after) Covid-19 #5. Now, “While Pear has an advantage over the competition in that its products are backed by randomized clinical trials, physicians and health plans are still working out how to prescribe and pay for digital therapeutics.” The FDA clears Somryst, Pear’s digital therapeutic to treat chronic insomnia #6. Net net, now is the time for individual and collective action to shift to a healthier “new normal” for all: 3 ways to protect your mental health during –and after– COVID-19 (in Spanish: Tres hábitos de higiene mental para vencer al COVID-1...
Source: SharpBrains - Category: Neuroscience Authors: Tags: Attention and ADD/ADHD Brain Teasers Cognitive Neuroscience Education & Lifelong Learning Health & Wellness Technology Adderall Alzheimer-disease Alzheimers-disease beta-amyloid brain teaser for adults Brain-Imaging brain-teaser Source Type: blogs